Certified by Founder Lodge
Mediar Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $105,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mediar Therapeutics is a biotechnology company pioneering a new approach to fibrosis treatment that halts the disease at a different source – the fibrotic mediators that drive disease progres
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 15 ,2023 | Unknown | $105,000,000 |
Eli Lilly and Company
Pfizer
Sofinnova Partners
Mission BioCapital
Mass General Brigham Ventures
Bristol Myers Squibb
Pureos Bioventures
Gimv
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)
